Join
Live feed
·
PRReleasevia Quantisnow
Theratechnologies Inc. logo

Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide

ByQuantisnow·Wall Street's wire, on your screen.
THTX· Theratechnologies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track THTX (Theratechnologies Inc.) and more on Quantisnow.